JAK1 PTGS2 VHL Protein_kinase-like_domain_(1), D5MAV8,P10721-2,P10721 ND ND, not done;AA, amino acid;TC, thymic carcinoma;nt, nucleotide;TNEC, thymic neuroendocrine carcinoma; ref nt, reference nucleotide; AA, amino acid; ID, idenfication number;pPh2, polyphen2. Ex, exon; del, deletion; ins, insertion; *, stop codon; fs, frameshift AB AB AB B1 B1 B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 B3 B3 B3 B3 B3 B3 N  O  S   N  O  S   N  O  S   TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC TC  TNEC  TNEC  TNEC  TNEC  TNEC   Core pathway*  #   Gene\Pt #  1  2  3  4  5  6  6  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75  76  77 FRAMESHIFT INDEL *Core pathways are defined based on the significance of driver gene mutation enrichment across all cancer types (Vogelstein et al., Cancer Genome Landscape, Science 339,1546 -1558 , 2013 . INFRAME INDEL As several genes belongs to different core pathways (see Figure 2D ), cell cycle/apoptosis and PI3K/RAS/STAT were combined into single pathways respectively. NONSENSE Note that Bap1 could also be assigned to DNA damage control pathway (see Figure 2B ). 
